About Organon & Co. 
Organon & Co.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 96 Schemes (45.06%)
Foreign Institutions
Held by 216 Foreign Institutions (10.2%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
1,507 Million
(Quarterly Results - Dec 2025)
Net Profit:
-205 Million
Pharmaceuticals & Biotechnology
USD 2,106 Million (Small Cap)
3.00
NA
0.73%
8,066.00
0.00%
0.00






